The Pharmaceutical Research and Manufacturers of America (PhRMA) announced today the recipients of the 2013 Research & Hope Awards, “honoring outstanding achievements in vaccines research and immunization by individuals and research teams in the biopharmaceutical sector, academic/public research and health care provider communities.” Recipients of the PhRMA 2013 Research & Hope Awards are:
:: The PhRMA Research & Hope Award for Biopharmaceutical Industry Research in Vaccine Development – GlaxoSmithKline Malaria Vaccine Team
“The GlaxoSmithKline Malaria Vaccine Team, led by Dr. Sophie Biernaux, is receiving the 2013 PhRMA Research & Hope Award for Biopharmaceutical Industry Research for its ongoing development of a vaccine against malaria targeted to children in Sub-Saharan Africa. For more information on the team’s work, now in the final stages of a large, multi-center Phase III clinical trial, see the video and team bio.”
:: The PhRMA Research & Hope Award for Academic or Public Research in Vaccine Development – Douglas R. Lowy, MD, National Cancer Institute; John T. Schiller, PhD, National Cancer Institute
“Drs. Lowy and Schiller are receiving the 2013 PhRMA Research & Hope Award for Academic or Public Research for the discovery of the human papilloma virus (HPV) vaccine for the prevention of cervical cancer. For more information on their pivotal work, see the video and bios.”
:: The PhRMA Research & Hope Award for Patient and Community Health – Linda Yu-Sing Fu, M.D., M.Sc., Children’s National Medical Center (CNMC)
“Dr. Fu, on behalf of her team at CNMC, is receiving the 2013 PhRMA Research & Hope Award for Patient and Community Health for their efforts to increase awareness of the importance of childhood immunization and raise the quality of immunization delivery to an at-risk population in the District of Columbia. For more information, see the video and bio.”
PhRMA noted that recipients of the Biopharmaceutical Industry Research and Academic or Public Research Awards were selected by the Science Advisory Board of the PhRMA Foundation following an open nominations process. The recipient of the Patient and Community Health Award was chosen by an inter-departmental committee of representatives from PhRMA.